Stryker ROE 2006-2019 | SYK

Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Stryker ROE for the three months ending June 30, 2019 was 25.98%.
Stryker ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $3.55B $11.94B 31.40%
2019-03-31 $3.52B $11.69B 32.96%
2018-12-31 $3.55B $11.73B 35.29%
2018-09-30 $1.24B $9.86B 12.83%
2018-06-30 $1.08B $9.46B 11.05%
2018-03-31 $1.02B $9.22B 10.28%
2017-12-31 $1.02B $9.98B 10.16%
2017-09-30 $1.78B $10.43B 17.92%
2017-06-30 $1.70B $10.04B 17.61%
2017-03-31 $1.69B $9.70B 17.93%
2016-12-31 $1.65B $9.55B 17.91%
2016-09-30 $1.66B $9.33B 18.56%
2016-06-30 $1.61B $9.10B 18.39%
2016-03-31 $1.62B $8.81B 18.85%
2015-12-31 $1.44B $8.51B 17.02%
2015-09-30 $1.18B $8.48B 13.89%
2015-06-30 $0.93B $8.51B 10.96%
2015-03-31 $0.67B $8.32B 7.75%
2014-12-31 $0.52B $8.60B 5.84%
2014-09-30 $0.64B $8.62B 7.17%
2014-06-30 $0.69B $9.00B 7.67%
2014-03-31 $0.77B $9.06B 8.71%
2013-12-31 $1.01B $9.05B 11.55%
2013-09-30 $0.89B $8.74B 10.35%
2013-06-30 $1.14B $8.60B 13.41%
2013-03-31 $1.25B $8.46B 15.01%
2012-12-31 $1.30B $8.60B 15.77%
2012-09-30 $1.43B $8.36B 17.85%
2012-06-30 $1.40B $7.95B 17.98%
2012-03-31 $1.39B $8.02B 17.89%
2011-12-31 $1.35B $7.68B 17.66%
2011-09-30 $1.24B $7.56B 16.54%
2011-06-30 $1.25B $7.78B 16.82%
2011-03-31 $1.26B $7.45B 17.55%
2010-12-31 $1.27B $7.17B 18.25%
2010-09-30 $1.28B $7.31B 18.80%
2010-06-30 $1.18B $6.75B 17.78%
2010-03-31 $1.15B $6.67B 17.82%
2009-12-31 $1.11B $6.60B 17.91%
2009-09-30 $1.08B $6.44B 18.34%
2009-06-30 $1.12B $6.06B 19.69%
2009-03-31 $1.14B $5.63B 19.81%
2008-12-31 $1.15B $5.41B 19.72%
2008-09-30 $1.15B $5.75B 19.71%
2008-06-30 $1.10B $6.22B 19.43%
2008-03-31 $1.07B $5.93B 20.02%
2007-12-31 $1.02B $5.38B 20.54%
2007-09-30 $0.97B $5.16B 20.81%
2007-06-30 $0.93B $4.80B 21.27%
2007-03-31 $0.87B $4.49B 21.27%
2006-12-31 $0.78B $4.19B 20.16%
2006-09-30 $0.73B $3.99B 20.02%
2006-06-30 $0.66B $3.77B 19.34%
2006-03-31 $0.63B $3.49B 19.39%
2005-12-31 $0.64B $3.30B 20.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $80.642B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Boston Scientific (BSX) United States $53.170B 25.79
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00